| Literature DB >> 34149117 |
Aliakbar Pourhatami1, Mohammad Kaviyani-Charati2, Bahareh Kargar3, Hamed Baziyad1, Maryam Kargar4, Carlos Olmeda-Gómez5.
Abstract
Over the two last decades, coronaviruses have affected human life in different ways, especially in terms of health and economy. Due to the profound effects of novel coronaviruses, growing tides of research are emerging in various research fields. This paper employs a co-word analysis approach to map the intellectual structure of the coronavirus literature for a better understanding of how coronavirus research and the disease itself have developed during the target timeframe. A strategic diagram has been drawn to depict the coronavirus domain's structure and development. A detailed picture of coronavirus literature has been extracted from a huge number of papers to provide a quick overview of the coronavirus literature. The main themes of past coronavirus-related publications are (a) "Antibody-Virus Interactions," (b) "Emerging Infectious Diseases," (c) "Protein Structure-based Drug Design and Antiviral Drug Discovery," (d) "Coronavirus Detection Methods," (e) "Viral Pathogenesis and Immunity," and (f) "Animal Coronaviruses." The emerging infectious diseases are mostly related to fatal diseases (such as Middle East respiratory syndrome, severe acute respiratory syndrome, and COVID-19) and animal coronaviruses (including porcine, turkey, feline, canine, equine, and bovine coronaviruses and infectious bronchitis virus), which are capable of placing animal-dependent industries such as the swine and poultry industries under strong economic pressure. Although considerable research into coronavirus has been done, this unique field has not yet matured sufficiently. Therefore, "Antibody-virus Interactions," "Emerging Infectious Diseases," and "Coronavirus Detection Methods" hold interesting, promising research gaps to be both explored and filled in the future. © Akadémiai Kiadó, Budapest, Hungary 2021.Entities:
Keywords: COVID-19; Co-word analysis; Coronavirus; Emerging infectious diseases; Science mapping; Text mining
Year: 2021 PMID: 34149117 PMCID: PMC8204734 DOI: 10.1007/s11192-021-04038-2
Source DB: PubMed Journal: Scientometrics ISSN: 0138-9130 Impact factor: 3.238
Fig. 1Coronavirus types
Fig. 2A comprehensive framework of intellectual structure based on co-word analysis
An example of a normalized co-occurrence matrix
| COVID-19 | SARS-CoV-2 | 2019-nCoV | MERS | SARS | |
|---|---|---|---|---|---|
| COVID-19 | 1 | 0.4419 | 0.1791 | 0.0039 | 0.0145 |
| SARS-CoV-2 | 0.4419 | 1 | 0.1731 | 0.0013 | 0.0140 |
| 2019-nCoV | 0.1791 | 0.1731 | 1 | 0.0053 | 0.0113 |
| MERS | 0.0039 | 0.0013 | 0.0053 | 1 | 0.0433 |
| SARS | 0.0145 | 0.0140 | 0.0113 | 0.0433 | 1 |
Fig. 3Strategic diagram of density and centrality
Fig. 4Quantification of papers on coronavirus topics (between 2000 and 2020, updated on April 1, 2020)
Highly frequent keywords in 13,518 papers
| No. | Keyword | Occurrences | No | Keyword | Occurrences |
|---|---|---|---|---|---|
| 1 | Respiratory disease | 2630 | 16 | Antibody | 762 |
| 2 | Spike | 1429 | 17 | Enteritis | 733 |
| 3 | Cats | 1349 | 18 | Emerging | 706 |
| 4 | Human | 1334 | 19 | AR-PCR | 701 |
| 5 | Pathogen | 1329 | 20 | Receptor | 695 |
| 6 | PCR | 1238 | 21 | Protease | 677 |
| 7 | RNA | 1215 | 22 | Response | 661 |
| 8 | E-protein | 1165 | 23 | Pneumonia | 619 |
| 9 | Diarrhea | 995 | 24 | Control | 606 |
| 10 | Middle East | 920 | 25 | Influenza | 598 |
| 11 | Spike protein | 888 | 26 | Replication | 596 |
| 12 | Epidemic | 843 | 27 | Vaccines | 585 |
| 13 | Antivirals | 830 | 28 | Nucleocapsid | 584 |
| 14 | Epidemiology | 791 | 29 | Recombinant | 549 |
| 15 | Respiratory tract | 780 | 30 | Diagnosis | 526 |
Leading journals in terms of number of coronavirus-related publications (2000–2020)
| Journal | # papers | % |
|---|---|---|
| Journal of virology | 907 | 6.7621 |
| Emerging infectious diseases | 314 | 2.341 |
| Virology | 303 | 2.259 |
| PLoS ONE | 261 | 1.9459 |
| Virus Research | 201 | 1.4985 |
| Journal of general virology | 193 | 1.4389 |
| Viruses-Basel | 177 | 1.3196 |
| Archives of virology | 162 | 1.2078 |
| Antiviral research | 154 | 1.1481 |
| Journal of virological methods | 152 | 1.1332 |
| Veterinary microbiology | 147 | 1.0960 |
| Journal of medical virology | 138 | 1.0289 |
| Journal of infectious diseases | 122 | 0.9096 |
| Journal of clinical virology | 121 | 0.9021 |
| Vaccine | 118 | 0.8797 |
| Journal of clinical microbiology | 117 | 0.8723 |
| Proceedings of the National Academy of Sciences of the United States of America | 117 | 0.8723 |
| Clinical infectious diseases | 113 | 0.8425 |
| Virology Journal | 110 | 0.8201 |
| Lancet | 108 | 0.8052 |
| Total | 13,518 | 100 |
Fig. 5The co-word network of coronaviruses
Modularity measurement of the communities yielded by the community detection algorithm
| Id | Cluster | No. sub-communities | Modularity |
|---|---|---|---|
| C1 | “Antibody-virus interactions” | – | – |
| C2 | “Emerging infectious diseases” | 7 | 0.421 |
| C3 | “Protein structure-based Drug design and antiviral drug discovery” | 7 | 0.436 |
| C4 | “Coronavirus Detection methods” | 6 | 0.308 |
| C5 | “Viral Pathogenesis and immunity” | – | – |
| C6 | “Animal coronaviruses” | 6 | 0.383 |
Fig. 6The main themes of coronavirus
Fig. 7“Antibody-virus interactions C1”
Fig. 8Illustration of the coronavirus structure and the ACE2 viral receptor
Fig. 9“Emerging infectious diseases C2”
Fig. 10“Protein structure-based drug design and antiviral drug discovery C3”
Fig. 11“Coronavirus detection methods C4”
Fig. 12“Viral pathogenesis and immunity C5”
Fig. 13“Animal coronaviruses C6”
The strategic diagram measurement
| Q | ID | Top keywords | Centrality | No. nodes | No. edges | Density |
|---|---|---|---|---|---|---|
| QI: Motor | – | – | – | – | – | – |
| QII: Ivory towers | C1 | Spike, spike protein, E protein, glycoprotein, entry, fusion, spike glycoprotein, membrane fusion, antibodies, and receptor | 3321 | 30 | 267 | 0.613793 |
| C5 | Demyelination, immunology, inflammation, response, pathogenesis, immune responses, multiple sclerosis, neuroimmunology, neuroinflammation, and hepatitis | 2694 | 36 | 324 | 0.514286 | |
| QIII: Emerging/Declining | C3 | Replication, protease, inhibitor, docking, antiviral, structure, nucleocapsid, molecular docking, and nucleocapsid protein | 6408 | 83 | 1036 | 0.3044 |
| QIV: Basic/Transversal, Bandwagon | C2 | Emerging infectious disease, infectious diseases, emerging infectious diseases, emergence, disease, control, Middle East, outbreak, dromedary, and Ebola | 7331 | 107 | 2013 | 0.354963 |
| C4 | RTI, respiratory tract, metapneumovirus, human metapneumovirus, rhinovirus, infections, respiratory syncytial virus, respiratory viruses, bocavirus, and human | 5355 | 93 | 1652 | 0.386162 | |
| C6 | Diarrhea, PED, enteritis, epidemic, infectious bronchitis, canine, gastroenteritis, bovine, phylogenetic analysis, and enteric | 6481 | 128 | 2274 | 0.279774 |
Fig. 14Strategic diagram